You searched for "screening"
Penile augmentation using injectable filler
Penile size is a major topic for many men and a source of anxiety throughout history. The common belief that a large penis is necessary to impress and satisfy their sexual partners has led to the notion that ‘bigger is...The High Operation
In this series of articles I am going to show you some of the exhibits contained in the BAUS Virtual museum of the History of Urology which is part of the BAUS website (www.baus.org.uk). In the last three articles I...Intelligent triage: improving outpatient efficiency
Background Improving outpatient (OP) efficiency and service structure is of paramount importance as the NHS seeks to manage ever increasing demand in the wake of the COVID-19 pandemic. As we re-establish services and attempt to clear the backlog, new ways...In conversation with Carmel Ramage
Carmel Ramage. Can you tell us a little bit about what first attracted you to medicine and then what led you to specialise in urogynaecology? To be honest, I’m not sure I ever really made a conscious decision about my...Dietary citrate substitution in urolithiasis patients
Stone formation is dependent on supersaturation of urinary salts and urinary crystal retention. Urinary promoters (protein aggregates, cell debris) and inhibitors (citrate, magnesium, urinary macromolecules such as glycosaminoglycans and proteins) are involved in the process of stone formation [1]. Hypocitraturia...IBSA UK&I launches Perovial®: the first licensed injectable option for men with acute Peyronie’s disease
A clinically supported option for early intervention in a historically underdiagnosed and undertreated condition. IBSA UK&I today (Monday 2 February 2026) announces the launch of Perovial®, the first licensed hyaluronic acid injectable indicated for the management of Peyronie’s disease (PD)...Together for 35 years: leading change in paediatric bowel and bladder health.
ERIC, The Children’s Bowel & Bladder Charity, returns with its biennial conference. This is a key event for healthcare professionals featuring cutting-edge research, interactive workshops, practical demonstrations and much more. Around 1 in 9 children and young people in the...
Anti-VEGF and PD-1 combinations in renal cell carcinoma
Over the past decade, vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs) have been central to treating renal cell carcinoma (RCC), with oncologists refining dosing strategies to balance treatment efficacy with quality of life (QoL). Recently, the introduction of...
